Saturday, January 31, 2026

North Korea Is Letting Tourists Back In — But Only on Its Terms

North Korea is opening its tourism sector to Russian visitors, signaling a shift towards increased openness while maintaining strict controls.

Weight-Loss Drugs Could Cut Airline Fuel Bills by $580 Million—An Unexpected Win for U.S. Carriers

The obesity treatment market is growing, helping U.S. airlines save on fuel costs due to decreased passenger weight.

Human Rights Groups Press Seoul to Confront North Korea Over 70 Years of Abductions

Families of North Korean abduction victims urge South Korea to address enforced disappearances and establish repatriation measures.

Health

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.
Latest

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Ceragem Draws 15,000 Visitors at CES 2026: Showcasing Its Vision for AI-Driven Wellness Homes

Ceragem's CES 2026 showcase attracted 15,000 visitors, highlighting AI-driven healthcare and positive feedback on innovative medical devices.

Kolmar BNH Wins Global HACCP at Two Plants: Raising Food Safety Standards to a Global Level

Kolmar BNH becomes the first health supplement ODM to achieve Global HACCP certification, enhancing food safety management standards.

When a Hangover Isn’t the Cause: Why Post-Drinking Palpitations May Signal Arrhythmia

Recent studies show that heart palpitations after drinking may signal arrhythmia, which can lead to severe complications if untreated.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Amid Rising Drug Resistance, Korea Begins DOMINO Trial to Reassess First-Line Treatment for Pediatric Mycoplasma

The DOMINO trial will assess treatments for pediatric Mycoplasma pneumonia, addressing rising macrolide resistance in Korea.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.